158 related articles for article (PubMed ID: 15239128)
1. Peroxiredoxins, a novel protein family in lung cancer.
Lehtonen ST; Svensk AM; Soini Y; Pääkkö P; Hirvikoski P; Kang SW; Säily M; Kinnula VL
Int J Cancer; 2004 Sep; 111(4):514-21. PubMed ID: 15239128
[TBL] [Abstract][Full Text] [Related]
2. Expression of peroxiredoxin and thioredoxin in human lung cancer and paired normal lung.
Park JH; Kim YS; Lee HL; Shim JY; Lee KS; Oh YJ; Shin SS; Choi YH; Park KJ; Park RW; Hwang SC
Respirology; 2006 May; 11(3):269-75. PubMed ID: 16635084
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma.
Kinnula VL; Lehtonen S; Sormunen R; Kaarteenaho-Wiik R; Kang SW; Rhee SG; Soini Y
J Pathol; 2002 Mar; 196(3):316-23. PubMed ID: 11857495
[TBL] [Abstract][Full Text] [Related]
4. Peroxiredoxins in breast carcinoma.
Karihtala P; Mäntyniemi A; Kang SW; Kinnula VL; Soini Y
Clin Cancer Res; 2003 Aug; 9(9):3418-24. PubMed ID: 12960131
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase 1 mRNA expression in lung cancer.
Sasaki H; Moriyama S; Nakashima Y; Kobayashi Y; Kiriyama M; Fukai I; Yamakawa Y; Fujii Y
Lung Cancer; 2004 Nov; 46(2):171-8. PubMed ID: 15474665
[TBL] [Abstract][Full Text] [Related]
6. Preferential elevation of Prx I and Trx expression in lung cancer cells following hypoxia and in human lung cancer tissues.
Kim HJ; Chae HZ; Kim YJ; Kim YH; Hwangs TS; Park EM; Park YM
Cell Biol Toxicol; 2003 Oct; 19(5):285-98. PubMed ID: 14703116
[TBL] [Abstract][Full Text] [Related]
7. Oxidative/nitrosative stress and peroxiredoxin 2 are associated with grade and prognosis of human renal carcinoma.
Soini Y; Kallio JP; Hirvikoski P; Helin H; Kellokumpu-Lehtinen P; Kang SW; Tammela TL; Peltoniemi M; Martikainen PM; Kinnula VL
APMIS; 2006 May; 114(5):329-37. PubMed ID: 16725008
[TBL] [Abstract][Full Text] [Related]
8. Selective expression of S100A7 in lung squamous cell carcinomas and large cell carcinomas but not in adenocarcinomas and small cell carcinomas.
Zhang H; Zhao Q; Chen Y; Wang Y; Gao S; Mao Y; Li M; Peng A; He D; Xiao X
Thorax; 2008 Apr; 63(4):352-9. PubMed ID: 18364444
[TBL] [Abstract][Full Text] [Related]
9. Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma.
Soini Y; Kahlos K; Näpänkangas U; Kaarteenaho-Wiik R; Säily M; Koistinen P; Pääakkö P; Holmgren A; Kinnula VL
Clin Cancer Res; 2001 Jun; 7(6):1750-7. PubMed ID: 11410516
[TBL] [Abstract][Full Text] [Related]
10. Cell specific expression of peroxiredoxins in human lung and pulmonary sarcoidosis.
Kinnula VL; Lehtonen S; Kaarteenaho-Wiik R; Lakari E; Pääkkö P; Kang SW; Rhee SG; Soini Y
Thorax; 2002 Feb; 57(2):157-64. PubMed ID: 11828047
[TBL] [Abstract][Full Text] [Related]
11. High-grade neuroendocrine carcinoma of the lung shows increased thymidylate synthase expression compared to other histotypes.
Ibe T; Shimizu K; Nakano T; Kakegawa S; Kamiyoshihara M; Nakajima T; Kaira K; Takeyoshi I
J Surg Oncol; 2010 Jul; 102(1):11-7. PubMed ID: 20578072
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of manganese superoxide dismutase and catalase in lung cancer.
Chung-man Ho J; Zheng S; Comhair SA; Farver C; Erzurum SC
Cancer Res; 2001 Dec; 61(23):8578-85. PubMed ID: 11731445
[TBL] [Abstract][Full Text] [Related]
13. LAT1 expression in non-small-cell lung carcinomas: analyses by semiquantitative reverse transcription-PCR (237 cases) and immunohistochemistry (295 cases).
Takeuchi K; Ogata S; Nakanishi K; Ozeki Y; Hiroi S; Tominaga S; Aida S; Matsuo H; Sakata T; Kawai T
Lung Cancer; 2010 Apr; 68(1):58-65. PubMed ID: 19559497
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic role of JC virus in lung cancer.
Zheng H; Abdel Aziz HO; Nakanishi Y; Masuda S; Saito H; Tsuneyama K; Takano Y
J Pathol; 2007 Jul; 212(3):306-15. PubMed ID: 17534844
[TBL] [Abstract][Full Text] [Related]
15. Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.
Woenckhaus M; Klein-Hitpass L; Grepmeier U; Merk J; Pfeifer M; Wild P; Bettstetter M; Wuensch P; Blaszyk H; Hartmann A; Hofstaedter F; Dietmaier W
J Pathol; 2006 Oct; 210(2):192-204. PubMed ID: 16915569
[TBL] [Abstract][Full Text] [Related]
16. Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients.
Yuan A; Yu CJ; Shun CT; Luh KT; Kuo SH; Lee YC; Yang PC
Int J Cancer; 2005 Jul; 115(4):545-55. PubMed ID: 15704107
[TBL] [Abstract][Full Text] [Related]
17. Characterization of neural cell types expressing peroxiredoxins in mouse brain.
Jin MH; Lee YH; Kim JM; Sun HN; Moon EY; Shong MH; Kim SU; Lee SH; Lee TH; Yu DY; Lee DS
Neurosci Lett; 2005 Jun; 381(3):252-7. PubMed ID: 15896479
[TBL] [Abstract][Full Text] [Related]
18. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.
Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE
Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021
[TBL] [Abstract][Full Text] [Related]
19. Nuclear factor E2-related factor 2 dependent overexpression of sulfiredoxin and peroxiredoxin III in human lung cancer.
Kim YS; Lee HL; Lee KB; Park JH; Chung WY; Lee KS; Sheen SS; Park KJ; Hwang SC
Korean J Intern Med; 2011 Sep; 26(3):304-13. PubMed ID: 22016591
[TBL] [Abstract][Full Text] [Related]
20. Caveolins as tumour markers in lung cancer detected by combined use of cDNA and tissue microarrays.
Wikman H; Seppänen JK; Sarhadi VK; Kettunen E; Salmenkivi K; Kuosma E; Vainio-Siukola K; Nagy B; Karjalainen A; Sioris T; Salo J; Hollmén J; Knuutila S; Anttila S
J Pathol; 2004 May; 203(1):584-93. PubMed ID: 15095482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]